These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2495797)

  • 1. Sex hormone-mediated effects on the phase I and phase II metabolism of N-2-fluorenylacetamide. Modulation of 9-hydroxylation.
    Malejka-Giganti D; Magat WJ; Decker RW
    Biochem Pharmacol; 1989 Apr; 38(7):1075-82. PubMed ID: 2495797
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide.
    Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR
    Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modifications of carcinogen metabolism in hepatic microsomes of suckling young by 3-methylcholanthrene or beta-naphthoflavone administered to lactating rats.
    Malejka-Giganti D; Decker RW; Ritter CL
    Biochem Pharmacol; 1983 Nov; 32(22):3335-44. PubMed ID: 6316979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microsomal metabolism of the carcinogen, N-2-fluorenyl-acetamide, by the mammary gland and liver of female rats. II. Glucuronidation of ring- and N-hydroxylated metabolites of N-2-fluorenylacetamide.
    Malejka-Giganti D; Ryzewski CN
    Carcinogenesis; 1985 May; 6(5):687-92. PubMed ID: 3924428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifications of hepatic microsomal 9-oxidation of N-2-fluorenylacetamide in response to gonadectomy and treatment of rats with phenobarbital or diethylnitrosamine.
    Malejka-Giganti D; Magat WJ; Decker RW
    Xenobiotica; 1989 Apr; 19(4):431-44. PubMed ID: 2501941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates.
    Malejka-Giganti D; Rydell RE; Gutmann HR
    Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute or chronic treatment of rats with N-2-fluorenylacetamide on its N-hydroxylation and on hemoproteins of hepatic microsomes.
    Malejka-Giganti D; Ritter CL
    Res Commun Chem Pathol Pharmacol; 1980 Apr; 28(1):53-64. PubMed ID: 7394317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamide.
    Malejka-Giganti D; McIver RC; Rydell RE
    J Natl Cancer Inst; 1980 Jun; 64(6):1471-7. PubMed ID: 6929383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mixed function oxidase in the mammary gland and liver microsomes of lactating rats. Effects of 3-methylcholanthrene and beta-naphthoflavone.
    Ritter CL; Malejka-Giganti D
    Biochem Pharmacol; 1982 Jan; 31(2):239-47. PubMed ID: 6277340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450.
    Goldstein JA; Weaver R; Sundheimer DW
    Cancer Res; 1984 Sep; 44(9):3768-71. PubMed ID: 6744296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice.
    Reddy TV; Weisburger EK; Thorgeirsson SS
    J Natl Cancer Inst; 1980 Jun; 64(6):1563-9. PubMed ID: 6929392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
    Kupfer D; Mani C; Lee CA; Rifkind AB
    Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development.
    Katayama S; Ohmori T; Maeura Y; Croci T; Williams GM
    J Natl Cancer Inst; 1984 Jul; 73(1):141-9. PubMed ID: 6588222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Debenzoylating and deacetylating activities of rat liver and mammary gland microsomes. Effect of ovariectomy.
    Ritter CL; Malejka-Giganti D
    Biochem Pharmacol; 1995 Oct; 50(8):1265-72. PubMed ID: 7488243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of the inhibitory action of p-hydroxyacetanilide on carcinogenesis by N-2-fluorenylacetamide or N-hydroxy-N-2-fluorenylacetamide.
    Mohan LC; Grantham PH; Weisburger EK; Weisburger JH; Idoine JB
    J Natl Cancer Inst; 1976 Apr; 56(4):763-8. PubMed ID: 815562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl sulfotransferase IV deficiency in rat liver carcinogenesis initiated with diethylnitrosamine and promoted with N-2-fluorenylacetamide or its C-9-oxidized metabolites.
    Malejka-Giganti D; Ringer DP; Vijayaraghavan P; Kiehlbauch CC; Kong J
    Exp Mol Pathol; 1997 Apr; 64(2):63-77. PubMed ID: 9316585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of liver microsomal cytochrome P450 in cynomolgus monkeys.
    Bullock P; Pearce R; Draper A; Podval J; Bracken W; Veltman J; Thomas P; Parkinson A
    Drug Metab Dispos; 1995 Jul; 23(7):736-48. PubMed ID: 7587963
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic processing of 2-acetylaminofluorene by microsomes and six highly purified cytochrome P-450 forms from rabbit liver.
    McManus ME; Minchin RF; Sanderson N; Schwartz D; Johnson EF; Thorgeirsson SS
    Carcinogenesis; 1984 Dec; 5(12):1717-23. PubMed ID: 6499123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
    Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
    FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunochemical identity of the 2,3,7,8-tetrachlorodibenzo-p-dioxin- and beta-naphthoflavone-induced cytochrome P-450 arachidonic acid epoxygenases in chick embryo liver: distinction from the omega-hydroxylase and the phenobarbital-induced epoxygenase.
    Kanetoshi A; Ward AM; May BK; Rifkind AB
    Mol Pharmacol; 1992 Dec; 42(6):1020-6. PubMed ID: 1480130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.